Welcome to our dedicated page for COMPUTER PROGRAMS & SYSTEMS news (Ticker: CPSI), a resource for investors and traders seeking the latest updates and insights on COMPUTER PROGRAMS & SYSTEMS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect COMPUTER PROGRAMS & SYSTEMS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of COMPUTER PROGRAMS & SYSTEMS's position in the market.
CPSI reported second quarter 2022 revenues of $82.7 million, up from $68.5 million year-over-year. GAAP net income was $3.1 million ($0.21 per diluted share), down from $6.1 million ($0.42 per diluted share) a year ago. For the first half of 2022, total revenues reached $160.6 million, an increase from $136.5 million in 2021. Cash provided by operations declined to $7.3 million in Q2 from $19.4 million in the prior year. Matt Chambless, CFO, noted that while the company achieved record bookings, profitability was affected by non-recurring revenue declines and increased costs.
CPSI (NASDAQ: CPSI), a community healthcare solutions company, will release its financial results for Q2 ended June 30, 2022, on Tuesday, August 2, 2022, after market close. A conference call will be held at 4:30 p.m. Eastern Time on the same day to discuss the results. Investors can access the live broadcast via the company's website, www.cpsi.com, with a replay available for 30 days post-event.
CPSI provides healthcare solutions to community hospitals and their clinics, enhancing patient care and operations.
CPSI (NASDAQ: CPSI) has launched a pilot of its Quippe Clinical Lens technology in partnership with Medicomp Systems. This new tool integrates with CPSI's Patient Data Console to streamline access to relevant clinical information, enhancing decision-making for healthcare providers. The technology aims to alleviate the burdens of data management, which are intensified by the ongoing challenges in healthcare staffing and operations. The announcement was made during the National Client Conference held from May 16-19 in St. Louis, Missouri.
CPSI (NASDAQ: CPSI) recently hosted its National Client Conference from May 16 to 19 in St. Louis, Missouri, attracting over 800 attendees from various healthcare sectors. The company introduced the Dream Factory, an initiative designed to streamline the development of innovative healthcare solutions, utilizing technology and employee-generated ideas. This aligns with CPSI's three-year strategic innovation plan. The initiative aims to enhance client services through a collaborative approach, integrating AI technologies and cloud solutions.
CPSI reported first-quarter 2022 revenues of $77.9 million, up from $68.0 million year-over-year. GAAP net income reached $8.1 million ($0.55 per diluted share), increasing from $4.1 million ($0.28 per diluted share) in 2021. Non-GAAP net income was $11.6 million. Adjusted EBITDA stood at $16.2 million, while bookings totaled $20.4 million. Cash from operations was $11.8 million, slightly down from $13.7 million last year. The company also amended its credit facilities to support M&A and organic growth strategies.
CPSI (NASDAQ: CPSI) announced the retirement of Boyd Douglas as President and CEO, effective June 30, 2022. Chris Fowler, the Chief Operating Officer, has been named as his successor. Douglas will remain a senior advisor until December 31, 2022, assisting in the leadership transition. Under Fowler's leadership since 2008, the TruBridge subsidiary saw revenue grow from $25 million to an anticipated $185 million in 2022. The Board expressed confidence in Fowler's ability to lead CPSI during its ongoing transformation towards growth and digital innovation.
CPSI (NASDAQ: CPSI), a community healthcare solutions provider, is set to release its financial results for Q1 ended March 31, 2022, on May 3, 2022, after market close. A conference call will follow at 4:30 p.m. ET, featuring a live broadcast accessible via www.cpsi.com. The call will be available for replay online for 30 days post-event. CPSI, founded in 1979, operates five companies aiming to enhance community health and improve patient care experiences.
American HealthTech (AHT), a subsidiary of CPSI (NASDAQ: CPSI), announced expansions with two clients in the post-acute sector, Central Management and Priority Management. Central Management opted for AHT solutions for a new facility due to positive staff experiences, emphasizing improved clinical workflows and staff efficiencies. Priority Management, with 23 facilities, also chose AHT for four new facilities, focusing on enhancing care quality and staff experience. AHT's partnerships reflect its commitment to innovation and support for client growth.
CPSI has acquired Healthcare Resource Group, Inc. (HRG), enhancing its revenue cycle management services. The transaction aims to address the growing demand for outsourcing RCM operations in healthcare. In 2021, HRG reported revenues of
CPSI reported its fourth quarter 2021 results, with revenues reaching $74.0 million, up from $66.8 million in Q4 2020. GAAP net income was $5.4 million or $0.37 per diluted share, an increase from $3.1 million in the prior year. Total revenues for 2021 were $280.6 million, compared to $264.5 million in 2020. CPSI expects 2022 total revenues between $288 million and $298 million. The company aims for a three-year annual organic recurring revenue growth of 5% to 8%.